Developing and validating stability-indicating methods

LC-GC North America

Volumn 23, Issue 6, 2005, Pages 586-593

  Swartz, Michael ^a,b   Krull, Ira ^b,c  

^a WATERS CORPORATION   (United States)

^b LCGC's Editorial Advisory Board ^*  (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ACIDITY; ALKALINITY; ANALYTIC METHOD; DRUG DEGRADATION; DRUG IMPURITY; DRUG PACKAGING; DRUG QUALITY; DRUG STABILITY; DRUG STORAGE; ENVIRONMENTAL FACTOR; FLUORESCENCE; HUMIDITY; LIGHT; LIQUID CHROMATOGRAPHY; PH; PHOTOLYSIS; QUANTITATIVE ANALYSIS; REVIEW; SEPARATION TECHNIQUE; SHELF LIFE; TEMPERATURE SENSITIVITY; THERMOSTABILITY; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

EID: 21144448403     PISSN: 15275949     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. ICH Q1A: Stability Testing of New Drug Substances and Products. (International Conference on Harmonization of Technical Requirements for the Registration of Drugs For Human Use, Geneva, Switzerland, February 2003). See also at www.ICH.org.
2. ICH Q1B: Stability Testing: Photostability Testing of New Drug Substances and Products (International Conference on Harmonization of Technical Requirements for the Registration of Drugs For Human Use, Geneva, Switzerland, November 1996). See also at www.ICH.org.
3. Guidance for Industry, Analytical Procedures and Method Validation, U.S. Department of Health and Human Services FDA, August 2000 (www.fda.gov/guidance/ index.htm).
4. D.W. Reynolds, Am. Pharm. Rev., May/June, 56-61 (2004).
5. M.E. Swartz, M.D. Jones, and M.A. Andrews, LCGC Application Notebook, 66-67 (June 2002).
6. L. Snyder, J.J. Kirkland, and J. Glajch. Practical HPLC Method Development, 2nd ed. (Wiley-Interscience Publishers, New York, 1997).
7. U.D. Neue, T.H. Walter, B.A. Alden, Z. Jiang, R.P. Fisk, J.T. Cook, K.H. Glose, J.L. Carmody, J.M. Grassi, Y.-F. Cheng, Z. Lu, and R.J. Crowley, Am. Lab. 31, 36 (1999).
8. Y.-F. Cheng, T.H. Walter, Z. Lu, P. Iraneta, C. Gendreau, U.D. Neue, J.M. Grassi, J.L. Carmody, J.E. O'Gara, and R.P. Fisk, LCGC 18(10), 1162 (2000).
9. The United States Pharmacopeia 25/National Formulary 20, Ch. 1225, pg. 2256-2259. (The United States Pharmacopeial Convention, Inc., Rockville, Maryland, 2002).
10. ICH Q2B: Validation of Analytical Procedures: Methodology (International Conference on Harmonization of Technical Requirements for the Registration of Drugs For Human Use, Geneva, Switzerland, May 1997).
11. ICH Q2B: Validation of Analytical Procedures: Methodology (International Conference on Harmonization of Technical Requirements for the Registration of Drugs For Human Use, Geneva, Switzerland, May 1997).
12. M.V. Gorenstein, J.B. Li, J. Van Antwerp, and D. Chapman, LCGC 12(10), 768-772 (1994).
13. P.M. Young and M.V. Gorenstein, LCGC 12(11), 832-838 (1994).
14. W.J. Warren, W.A. Stanick, M.V. Gorenstein, and P.M. Young, BioTechniques 18(2), 282-297 (1995).
15. M.E. Swartz, J. Liq. Chrom. 28(7/8), 1253-1263 (2005).
16. M. Swartz and B. Murphy, Am. Lab. 37(3), 22-27 (2005).
17. M. Swartz, Pharm. Formulation Quality 6(5), 40-42 (2004).
18. I.S. Krull and M.E. Swartz, LCGC 15(6) 534-540 (1997).
19. M.E. Swartz and I.S. Krull, Analytical Method Development and Validation (Marcel Dekker, New York, 1997).
20. J. Orr, I.S. Krull, and M.E. Swartz, LCGC 21(7), 626 (2003).
21. J. Orr, M.E. Swartz, and I.S. Krull, LCGC 21(12), 1146 (2003).